MedPath

A Pilot Research Project on Outcome of Trauma Informed Stabilization Treatment (TIST) for Adults with Complex Trauma Symptoms After Childhood Trauma, At the Department of Trauma Treatment, Modum Bad, Norway

Conditions
PTSD and Trauma-related Symptoms
PTSD
Registration Number
NCT06719167
Lead Sponsor
Modum Bad
Brief Summary

The purpose of the study is to examine the effects of residential group and individual Trauma Informed Stabilization Treatment (TIST) for complex symptoms in adult survivors of childhood trauma in a naturalistic observational study.

Detailed Description

Adult survivors of childhood trauma have complex and diverse symptom profiles. The aim of the study is to examine the effects of theTrauma Informed Stabilization Treatment (TIST) model, developed by dr Janina Fisher, in adult survivors of childhood trauma.

32 patients will be recruited from referrals to an residential open door trauma clinic in Norway, Modum Bad. Patients will be admitted for in-patient pre-planned treatment over 11 weeks - consisting of individual therapy and group therapy using different modalities, all within the TIST approach and framework. Patients will be summoned for 6 day follow-up 8 months after treatment.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Adults ≥18 years
  • Complex symptom presentations connected to childhood trauma
  • All patients will have undergone outpatient therapy with insufficient effect
  • Most included patients will have a diagnosis of complex PTSD (diagnosed by M.I.N.I. and clinical evaluation)
  • Patients may have diagnosis of unspecified dissociative disorder, personality disorders, depression and other comorbidity.

Exclusion criteria:

  • Dissociative identitiy disorder
  • Ongoing psychosis
  • Ongoing drug addiction
  • Very disturbed group function
  • Ongoing life crisis
  • Mental disability
  • Acute suicidality
  • Ongoing severe self harm
  • Patients with complex dissociative disorders and patients eligible for exposure therapy will be referred to/prioritized for other treatment programmes.
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difficulties in emotion regulation scale (DERS)Week 0 (Admission), week 11-12 (discharge) and 8 months follow up

Difficulties in emotion regulation scale, scale and subscales

Five facet mindfulness questionnaire (FFMQ)Week 0 (Admission), week 11-12 (discharge) and 8 months follow up

Five facet mindfulness questionnaire, all subscales

Self-compassion scale long form (SCS-LF)Week 0 (Admission), week 11-12 (discharge) and 8 months follow up

Self-compassion scale long form, scale and subscales

PTSD checklist for DSM-5 (PCL-5)Week 0 (Admission), week 11-12 (discharge) and 8 months follow up

PTSD checklist for DSM-5, scale and subscales

International trauma questionnaire (ITQ)Week 0 (Admission), week 11-12 (discharge) and 8 months follow up

International trauma questionnaire, scale and subscales

Secondary Outcome Measures
NameTimeMethod
Patient health questionnaire 9 (PHQ-9)Week 0 (Admission), week 11-12 (discharge) and 8 months follow up

Patient health questionnaire 9

Quality of lifeWeek 0 (Admission), week 11-12 (discharge) and 8 months follow up

Self report on scale of 0-10

Trial Locations

Locations (1)

Modum Bad

🇳🇴

Vikersund, Buskerud, Norway

© Copyright 2025. All Rights Reserved by MedPath